skip to Main Content
July 22, 2021 12:00 - 1:00 PM ET

Post-Pandemic Planning for Life Sciences Companies

  • This page as PDF


Avalere’s data analytics and market access experts will be joined by Jeff Patton, MD and CEO of OneOncology, to explore critical issues and considerations for life sciences stakeholders following the pandemic.

COVID-19 fundamentally changed the way patients experience the healthcare system. As the pandemic wanes, the biopharmaceutical industry will need to adjust its business practices to reflect the post-pandemic landscape and serve patients and customers effectively. In this webinar, Avalere experts will discuss key issues for consideration, including:

  • Predictive analytics to examine the evolving patient journey and utilization patterns, including telehealth use
  • Customer engagement strategies, including innovative approaches to segmentation and super customers
  • Next-generation patient support programs and the needs created by the shifting coverage landscape


Elizabeth Carpenter , Head of Advisory Services

Elizabeth specializes in policy, particularly in the implementation of the Affordable Care Act (ACA), trends in commercial insurance, drug pricing policy, and the impact of politics on the policy landscape.

Lance Grady , Practice Director, Market Access & Reimbursement

As the leader of the Market Access Practice, Lance Grady devises commercialization strategies focused on value, access, and reimbursement.

Nathan Markward , Principal Research Scientist, Health Economics & Advanced Analytics

Nathan Markward is principal research scientist for Avalere’s Health Economics and Advanced Analytics practice where he leads the conceptualization, execution, and delivery of comparative effectiveness, HEOR, performance improvement, and risk adjustment studies that drive opportunity identification and value creation for a diverse array of clients, including biopharmaceutical companies, device manufacturers, health plans, provider networks, patient advocacy groups, and medical societies.

Guest Speaker
Jeffrey F. Patton, M.D. , Chief Executive Officer, OneOncology
Jeff Patton, MD, is a board-certified hematologist and oncologist, Chief Executive Officer and Board of Directors member at OneOncology, where he also served as President of Physician Services for over a year.
From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about COVID-19 Intel Center
Please enter your email address to be notified when new COVID-19 Intel Center insights are published.

Back To Top